CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE
Should you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.
Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.
Elevance Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.
89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by company insiders. Comparatively, 0.3% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.
Elevance Health has a net margin of 3.89% compared to Elevance Health's net margin of 1.76%. Centene's return on equity of 20.64% beat Elevance Health's return on equity.
Centene received 179 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.23% of users gave Centene an outperform vote while only 67.01% of users gave Elevance Health an outperform vote.
Elevance Health presently has a consensus target price of $604.29, suggesting a potential upside of 14.55%. Centene has a consensus target price of $83.93, suggesting a potential upside of 14.81%. Given Elevance Health's higher probable upside, analysts plainly believe Centene is more favorable than Elevance Health.
In the previous week, Centene had 6 more articles in the media than Elevance Health. MarketBeat recorded 45 mentions for Centene and 39 mentions for Elevance Health. Centene's average media sentiment score of 0.34 beat Elevance Health's score of 0.07 indicating that Elevance Health is being referred to more favorably in the media.
Summary
Elevance Health beats Centene on 14 of the 19 factors compared between the two stocks.
Get Centene News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
